A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Conference Coverage
2008 Conference Coverage
Date:
Location:
Author:

ASCO 2008
May 30-June 2, 2008 - Chicago, IL

ASH 2008
December 6-9, 2008 - San Francisco, CA

SABCS 2008
December 10-14, 2008 - San Antonio, TX

A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists
March 9-12, 2008 - Tampa, FL

A report from the 2008 ASCO Genitourinary Cancers Symposium
February 14-16, 2008 - San Francisco, CA

Newsletters
Register in our member center today to receive a monthly newsletter with conference coverage updates.
Learn More »
Practice Resources
Learn how to have our conference coverage on your website.
Learn More »
Related News Stories
Picoplatin, a Third Generation Platinum Compound, Evaluated for SCLC, Prostate Cancer and Colorectal Cancer (7/13/2007)

Alimta®/Platinum-compound Combination Confirmed Active in Mesothelioma (6/28/2007)

Adjuvant Gleevec® May Prevent Recurrences in Resected GIST (6/26/2007)

Addition of Avastin® to Gemzar®/Platinol® Combination Improves Progression-free Survival in NSCLC (6/22/2007)

Axitinib May Be Effective in Advanced Thyroid Cancer (6/21/2007)

Avastin® Improves Progression-Free Survival in Metastatic Renal Cell Cancer (6/20/2007)

Intravenous Iron Improves Clinical Outcomes of Aranesp® Treatment of Chemotherapy-Induced Anemia (6/20/2007)

Axitinib plus Taxotere® Maybe Superior to Taxotere alone for Metastatic Breast Cancer (6/19/2007)

Dose- Dense Adjuvant Chemotherapy Supported by Epoetin Alfa for Breast Cancer not Associated with Increased Relapses (6/18/2007)

Oncotype DX™ Evaluated in Node-positive Breast Cancer (6/18/2007)

Axitinib, an Oral Tyrosine Kinase Inhibitor, has Activity in NSCLC (6/15/2007)

Satraplatin Effective for Treatment of Hormone Refractory Prostate Cancer (6/15/2007)

Intermittent Androgen Suppression Confirmed Effective in Advanced Prostate Cancer (6/14/2007)

Ginseng May Improve Cancer-Related Fatigue (6/14/2007)

MRI May Improve Detection of DCIS (6/13/2007)

Adjuvant Herceptin-related Heart Problems Defined (6/13/2007)

Nilotinib Effective in Patients with CML Intolerant to Gleevec® (6/12/2007)

Bosutinib: A New Kinase Inhibitor for Treatment of Philadelphia Chromosome Positive Leukemia (6/12/2007)

AMG 531 Maybe Effective in Treating Thrombocytopenia in Patients with MDS (6/11/2007)

Sprycel® Highly Effective as Initial Therapy in Chronic Myeloid Leukemia (6/7/2007)

Recurrence Rates for Liver Metastases Reduced When Neoadjuvant and Adjuvant Chemotherapy are Used With Surgery (6/6/2007)

Erbitux® Improves Survival in Head and Neck Cancer (6/6/2007)

Prophylactic Cranial Radiation Improves Survival in Extensive Small-Cell Lung Cancer (6/5/2007)

Nexavar® Improves Survival in Hepatocellular Carcinoma (6/5/2007)

Oncotype DX™ Influences Breast Cancer Treatment Choices (6/4/2007)

Cryoablation as Salvage Therapy for Recurrent Prostate Cancer after Radiation (6/1/2007)

High Intensity Ultrasound for the Treatment of Localized Prostate Cancer to be Studied in the US (5/31/2007)

Randomized Trial Indicates that Cryosurgery is Equivalent to Radiation Therapy for Prostate Cancer (5/30/2007)

Oral Satraplatin well Tolerated and Effective for Metastatic Prostate Cancer (5/29/2007)

Functional Outcomes of Robotic Prostatectomy Similar to Conventional Prostatectomy (5/29/2007)

Weekly Taxol®, Eloxatin®, Leucovorin and 5-FU Promising for Metastatic Pancreatic Cancer (3/23/2007)

Aranesp® Every 2 or 3 Weeks Confirmed as Effective as Weekly Schedule (3/12/2007)

Adjuvant Platinol®/Navelbine® Improves Survival in NSCLC (10/11/2006)

Statin Use May Lower Risk of Aggressive Prostate Cancer (1/19/2006)




© 1998-2007 CancerConsultants.com  All Rights Reserved.